Ovation Study
back to Current Trials
This study is for patients diagnosed with Parkinson's Disease who is experiencing psychosis. This is a 10 week study to evaluate the safety and efficacy of Melperone in the treatment of psychosis associated with Parkinson's Disease. This study is placebo controlled, meaning you will be randomized to either Melperone at different dosages or a placebo. Before entering into the study, we will have to determine your eligibility at the screening visit. This will involve blood work, a cardiogram (EKG) and neurological
If you are interested in knowing more about this clinical trial, please contact:
Research Worker
212.305.6121
af2161@columbia.edu
Clinical Trials Coordinator
212.305.6121
atam@neuro.columbia.edu
